Endogenous Sex Hormone Changes in Postmenopausal Women in the Diabetes Prevention Program
Catherine Kim, Shengchun Kong, Gail A. Laughlin et al. · The Journal of Clinical Endocrinology & Metabolism · 2012
CONTEXT: Whether endogenous sex hormones (ESH) [SHBG, estradiol, testosterone, and dehydroepiandrosterone (DHEA)] are altered by intensive lifestyle modification (ILS) or metformin and whether such changes affect glucose levels among dysglycemic postmenopausal women is unclear. OBJECTIVES: Our objective was to examine intervention impact on ESH and associations with fasting plasma glucose (FPG) and 2-h glucose changes among postmenopausal glucose-intolerant women. DESIGN: We performed a secondary analysis of a randomized controlled trial. PARTICIPANTS: Participants included postmenopausal, overweight, glucose-intolerant women not using exogenous estrogen (n = 382) who participated in the Diabetes Prevention Program. INTERVENTIONS: Interventions included ILS with the goals of weight reduction of at least 7% of initial weight and 150 min/wk of moderate intensity exercise or metformin or placebo administered 850 mg twice a day. MAIN OUTCOME MEASURES: Intervention-related changes in ESH and associations of changes in ESH and glucose levels were evaluated. RESULTS: ILS significantly increased SHBG and decreased DHEA before and after adjustment for changes in waist circumference and fasting insulin. ILS did not alter estradiol or testosterone. Metformin did not change any ESH. ILS-induced increases in SHBG and declines in DHEA were associated with decreases in FPG and 2-h glucose, and declines in estradiol were associated with decreases in FPG, before and after adjustment for age, FSH, race/ethnicity, changes in waist circumference, and 1/fasting insulin. CONCLUSIONS: Among postmenopausal glucose-intolerant women not using estrogen, ILS increased SHBG levels and lowered DHEA levels. These changes were associated with lower glucose independent of adiposity and insulin. Metformin effects upon ESH were not significant.
Cited by 25 works. doi:10.1210/jc.2012-1233
Authors
- Catherine Kim
- Shengchun Kong
- Gail A. Laughlin
- Sherita Hill Golden
- Kieren J. Mather
- Bin Nan
- Sharon L. Edelstein
- John F. Randolph
- Fernand Labrie
- Elizabeth Buschur
- Elizabeth Barrett‐Connor
References
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
- Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature
- Endogenous Sex Hormones and the Development of Type 2 Diabetes in Older Men and Women: the Rancho Bernardo Study
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men
- Role of Insulin Secretion and Sensitivity in the Evolution of Type 2 Diabetes in the Diabetes Prevention Program
- THE EFFECT OF WEIGHT LOSS ON SEX STEROID SECRETION AND BINDING IN MASSIVELY OBESE WOMEN
- Effect of Exercise on Serum Estrogens in Postmenopausal Women
- Fasting and 2-Hour Postchallenge Serum Glucose Measures and Risk of Incident Cardiovascular Events in the Elderly
- Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women
- The Influence of Age on the Effects of Lifestyle Modification and Metformin in Prevention of Diabetes